CGON
Cg Oncology Inc.
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Loading...
Open
38.96
Mkt cap
2.7B
Volume
267K
High
39.95
P/E Ratio
-35.04
52-wk high
50.23
Low
38.67
Div yield
N/A
52-wk low
25.77

Portfolio Pulse from Benzinga Newsdesk
August 27, 2024 | 10:24 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.